The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules

被引:95
作者
Battistutta, Roberto
Mazzorana, Marco
Cendron, Laura
Bortolato, Andrea
Sarno, Stefania
Kazimierczuk, Zygmunt
Zanotti, Giuseppe
Moro, Stefano
Pinna, Lorenzo A.
机构
[1] Univ Padua, Dept Chem Sci, I-35131 Padua, Italy
[2] Univ Padua, Dept Biol Chem, I-35121 Padua, Italy
[3] Univ Padua, Mol Modeling Sec, Dept Pharmaceut Sci, I-35131 Padua, Italy
[4] VIMM, Vet Inst Mol Med, I-35129 Padua, Italy
[5] Polish Acad Sci, Lab Expt Pharmacol, Med Res Ctr, PL-02106 Warsaw, Poland
关键词
D O I
10.1002/cbic.200700307
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CK2 is a highly pleiotropic Ser/Thr protein kinase that is able to promote cell survival and enhance the tumour phenotype under specific circumstances. We have determined the crystal structure of three new complexes with tetrabromobenzimidazole derivatives that display K-i values between 0.15 and 0.30 mu m. A comparative analysis of these data with those of four other inhibitors of the some family revealed the presence of some highly conserved water molecules in the ATP-binding site. These waters reside near Lys68, in an area with a positive electrostatic potential that is able to attract and orient negatively charged ligands. The presence of this positive region and two unique bulky residues that ore typical of CK2, Ile66 and Ile174, play a critical role in determining the ligand orientation and binding selectivity.
引用
收藏
页码:1804 / 1809
页数:6
相关论文
共 48 条
[1]   Targeting CK2 for cancer therapy [J].
Ahmad, KA ;
Wang, GX ;
Slaton, J ;
Unger, G ;
Ahmed, K .
ANTI-CANCER DRUGS, 2005, 16 (10) :1037-1043
[2]   Polyhalogenobenzimidazoles: Synthesis and their inhibitory activity against casein kinases [J].
Andrzejewska, M ;
Pagano, MA ;
Meggio, F ;
Brunati, AM ;
Kazimierczuk, Z .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (18) :3997-4002
[3]  
[Anonymous], ACTA CRYSTALLOGR D
[4]   The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2 [J].
Battistutta, R ;
Sarno, S ;
De Moliner, E ;
Papinutto, E ;
Zanotti, G ;
Pinna, LA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (38) :29618-29622
[5]   Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole [J].
Battistutta, R ;
Mazzorana, M ;
Sarno, S ;
Kazimierczuk, Z ;
Zanotti, G ;
Pinna, LA .
CHEMISTRY & BIOLOGY, 2005, 12 (11) :1211-1219
[6]   Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole [J].
Battistutta, R ;
De Moliner, E ;
Sarno, S ;
Zanotti, G ;
Pinna, LA .
PROTEIN SCIENCE, 2001, 10 (11) :2200-2206
[7]   Oncogenic kinase signalling [J].
Blume-Jensen, P ;
Hunter, T .
NATURE, 2001, 411 (6835) :355-365
[8]   In silico binding free energy predictability by using the linear interaction energy (LIE) method: Bromobenzimidazole CK2 inhibitors as a case study [J].
Bortolato, A. ;
Moro, S. .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (02) :572-582
[9]  
*CHEM COMP GROUP I, 2006, 200608 MOE
[10]   Protein kinases - the major drug targets of the twenty-first century? [J].
Cohen, P .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :309-315